Physician profile
Tracy Graham
NPI 1992022776
$787.98
in general payments reported to CMS, 2019-2025
13 companies · $37.61 in 2025
The $37.61 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $29.33 · 2021: $149 · 2022: $79.14 · 2023: $172 · 2024: $149 · 2025: $37.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.78 | 2021-2025 | |
| Penumbra, INC. | $133.87 | 2024-2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $128.01 | 2019-2022 | |
| Csl Behring | $64.90 | 2022-2023 | Kcentra |
| Pfizer INC. | $50.14 | 2019-2023 | |
| Inari Medical, INC. | $44.35 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $33.48 | 2023-2024 | Lokelma, Andexxa |
| Chiesi USA, INC. | $29.82 | 2019 | |
| Allergan, INC. | $29.33 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.24 | 2021 | |
| Novo Nordisk INC | $21.30 | 2023 | Rybelsus, Ozempic |
| Alexion Pharmaceuticals, INC. | $15.10 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.